These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16371926)

  • 41. How HCV has changed the approach to mixed cryoglobulinemia.
    Della Rossa A; Baldini C; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S115-23. PubMed ID: 19646357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cryoglobulin-induced cardiomyopathy.
    Karras A; Potier L; Reboux AH; Coldea N; Perdrix L; Jacquot C; Mousseaux E
    J Am Coll Cardiol; 2010 Feb; 55(7):e13. PubMed ID: 20170783
    [No Abstract]   [Full Text] [Related]  

  • 43. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Visentini M; Ludovisi S; Petrarca A; Pulvirenti F; Zaramella M; Monti M; Conti V; Ranieri J; Colantuono S; Fognani E; Piluso A; Tinelli C; Zignego AL; Mondelli MU; Fiorilli M; Casato M
    Autoimmun Rev; 2011 Sep; 10(11):714-9. PubMed ID: 21570494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful renal transplantation to a recipient with type II cryoglobulinemia: a case report.
    Kasagi T; Nobata H; Ikeda K; Banno S; Ito Y
    BMC Nephrol; 2018 Jul; 19(1):170. PubMed ID: 29986657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
    Uppal R; Charles E; Lake-Bakaar G
    J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.
    Lamprecht P; Lerin-Lozano C; Merz H; Dennin RH; Gause A; Voswinkel J; Peters SO; Gutzeit O; Arlt AC; Solbach W; Gross WL
    Ann Rheum Dis; 2003 Dec; 62(12):1230-3. PubMed ID: 14644867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cold agglutinin disease and cryoglobulinemia.
    Gertz MA
    Clin Lymphoma; 2005 Mar; 5(4):290-3. PubMed ID: 15794868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rituximab therapy for acute humoral rejection after kidney transplantation.
    Faguer S; Kamar N; Guilbeaud-Frugier C; Fort M; Modesto A; Mari A; Ribes D; Cointault O; Lavayssière L; Guitard J; Durand D; Rostaing L
    Transplantation; 2007 May; 83(9):1277-80. PubMed ID: 17496547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus infection and glomerular disease.
    Fabrizi F; Donato F; Messa P
    Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV-infected renal allograft recipients.
    Weiner SM; Thiel J; Berg T; Weber S; Krumme B; Peter HH; Rump LC; Grotz WH
    Clin Transplant; 2004 Feb; 18(1):7-13. PubMed ID: 15108765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study.
    Saadoun D; Ghembaza A; Riviere S; Mekinian A; Boutemy J; Leroux G; Domont F; Maillard H; Vautier M; Cacoub P
    J Autoimmun; 2021 Jan; 116():102577. PubMed ID: 33248866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cryoglobulinemia].
    Cacoub P; Sène D; Saadoun D
    Rev Med Interne; 2008 Mar; 29(3):200-8. PubMed ID: 18242787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II.
    Moberg P; Charles JF; Respicio G; Venna SS; Rooney T
    Cutis; 2010 Sep; 86(3):133-5. PubMed ID: 21049729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report.
    Pasquet F; Combarnous F; Macgregor B; Coppere B; Mausservey C; Ninet J; Hot A
    J Med Case Rep; 2012 Jan; 6():39. PubMed ID: 22284897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
    Bartel C; Obermüller N; Rummel MJ; Geiger H; Hauser IA
    Clin Nephrol; 2008 Apr; 69(4):285-9. PubMed ID: 18397703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relapse of membranous glomerulopathy after kidney transplantation: sustained remittance induced by rituximab.
    Weclawiak H; Ribes D; Guilbeau-Frugier C; Touchard G; Kamar N; Mehrenberger M; Modesto A; Rostaing L
    Clin Nephrol; 2008 May; 69(5):373-6. PubMed ID: 18538101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
    Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
    Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.